ALX (http://www.ALXAfrica.com/), Anthropic, and the Government of Rwanda have announced a landmark partnership to enhance learning and teaching across Africa through ...
Kigali, Rwanda – November 17, 2025 ALX, Anthropic, and the Government of Rwanda today announced a landmark partnership to revolutionize learning and teaching across Africa through artificial ...
Alexander’s (ALX) posted a net profit margin of 17.1%, down from 22.1% in the prior year, with earnings declining 2.5% per year over the past five years and negative earnings growth in the most recent ...
Allcargo Logistics’s wholly owned subsidiary, ALX Shipping Agencies India, has filed complaint against its own CEO and a business associate for alleged financial irregularities. According to a ...
Africa’s youth are brimming with ambition, but accessing world-class education and tech careers can feel like a distant dream. ALX Pathway is changing that, offering a transformative eight-month ...
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic ...
ALX Nigeria has unveiled Creative Tech Lite, a new initiative designed to equip the continent’s creators with in-demand digital skills. Touted as a game-changer for Africa’s creative economy, Creative ...
ALX Oncology Holdings Inc., a pharmaceutical company based in South San Francisco, California, has been notified of its non-compliance with a Nasdaq listing requirement. On April 23, 2025, the company ...
ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload platform ...
ALX, Africa’s leading tech career accelerator, is celebrating a major win for young African talent as 21 exceptional learners from the ALX Pathway program secure prestigious scholarships from the ...
ALX Oncology is cutting about 30% of its workforce and realigning its focus. The clinical-stage biotechnology company named Harish Shantharam as chief financial officer and Alan Sandler as chief ...
Shares of ALX Oncology (NASDAQ:ALXO) climbed on Thursday after Jefferies upgraded the cancer drug developer to Buy from Hold, arguing that its stock, following the recent selloff, has the potential to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results